http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990087835-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-04
filingDate 1998-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-19990087835-A
titleOfInvention Crystal variant of drug
abstract The present invention is formulan n n n n n n n Novel variants B and C of 1- (2,6-difluorobenzyl) -1H-1,2,3-triazole-4-carboxamide, compounds thereof, and pharmaceutical preparations comprising the crystal variants thereof It is about.
priorityDate 1997-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420917915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424482146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10888323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11042239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419733501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411329749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22716778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10014469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421074718

Total number of triples: 26.